This is an absolute failure.
anonymous Guest anonymous   Oct 11, 2018 at 11:56: AM #1 anonymous Guest This is an absolute failure.
anonymous Guest anonymous   Oct 11, 2018 at 06:44: PM #2 anonymous Guest After the BOD give him another $10-20M is stock. This bod likes paying a LOT for non performance.
anonymous Guest anonymous   Oct 11, 2018 at 07:32: PM #3 anonymous Guest At what point does Elliott Management, Third Point or others threaten a proxy contest this fall and move against the Board?
At what point does Elliott Management, Third Point or others threaten a proxy contest this fall and move against the Board?
anonymous Guest anonymous   Oct 12, 2018 at 11:30: AM #4 anonymous Guest Competition is getting closer and closer to a biosimilar. The day that one of them puts down a solid phase 3 trial this stock will be worthless.
Competition is getting closer and closer to a biosimilar. The day that one of them puts down a solid phase 3 trial this stock will be worthless.